NCT02604940View on ClinicalTrials.gov

Evaluation of Dexmedetomidine on Post-operative Narcotic Requirements and Pain Scores in Bariatric Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

June 25, 2018

Study Completion Date

June 25, 2018

Conditions
Pain
Interventions
DRUG

Dexmedetomidine

1mcg/kg IV dexmedetomidine over 10 minutes from 60ml syringe in OR upon notification of surgical closure

DRUG

Normal Saline

60ml Saline delivered over 10 minutes in OR upon notification of surgical closure.

Trial Locations (1)

26506

WVU Healthcare Ruby Memorial Hospital, Morgantown

All Listed Sponsors
lead

West Virginia University

OTHER

NCT02604940 - Evaluation of Dexmedetomidine on Post-operative Narcotic Requirements and Pain Scores in Bariatric Patients | Biotech Hunter | Biotech Hunter